ArticleHealth science reports2025
Impact of Polymorphisms in Genes Related to Vitamin D Metabolism on Serum Response to Supplementation in Adults and Elderly: A Systematic Review and Meta-Analysis Protocol.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Vitamin D deficiency is a major public health issue, with varying individual responses to supplementation. Genetic factors, especially single-nucleotide polymorphisms (SNPs) in Vitamin D metabolism genes, likely play a key role. This protocol proposes a systematic review to explore how genetic variability affects serum 25-hydroxyvitamin D [25(OH)D] levels after supplementation. Methods: This protocol adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). The literature search will be conducted across MEDLINE, Scopus, Web of Science, and Embase, without restrictions on publication date or language. The study selection will be guided by Population, Exposure, Comparator, Outcomes, Study Design (PECOS) framework, focusing on randomized clinical trials that report pre- and post-supplementation serum 25(OH)D levels alongside genotype data. Inclusion criteria comprise adults and elderly individuals, from both sexes and any ethnicity, who received Vitamin D supplementation and have SNPs data, while exclusion criteria reject studies with confounding factors such as pre-existing conditions or use of medications affecting Vitamin D status. Data extraction will include study characteristics, participant demographics, intervention details, SNPs, and serum 25(OH)D data. Inter-rater reliability will be assessed using Cohen's kappa coefficient. A descriptive synthesis will summarize the findings, and if feasible, a meta-analysis will be conducted. The primary outcome will be changes in serum 25(OH)D concentrations. Heterogeneity among studies will be quantified using the Conclusion: By identifying genetic subgroups with differential responses to vitamin D supplementation, the findings are expected to contribute to the development of personalized supplementation strategies. These insights may enhance health interventions by optimizing supplementation protocols based on genetic predispositions, ultimately improving health outcomes. Trial Registration: This protocol has been registered with International prospective register of systematic reviews (PROSPERO) ID: CRD42023449836.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.